Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The ...
GONZALEZ-RIVAS, J. P., J. I. MECHANICK, J. P. HERNANDEZ, M. M. INFANTE-GARCIA, Iuliia PAVLOVSKA, J. R. MEDINA-INOJOSA, Sarka KUNZOVA, R. NIETO-MARTINEZ, Jan BROZ, L. BUSETTO, G. A. M. NETO, F. LOPEZ-JIMENEZ, Jana URBANOVA a G. B. STOKIN. Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study. OBESITY SCIENCE & PRACTICE. HOBOKEN: WILEY, 2021, roč. 7, č. 5, s. 535-544. ISSN 2055-2238. Dostupné z: https://dx.doi.org/10.1002/osp4.496. |
Další formáty:
BibTeX
LaTeX
RIS
|
Základní údaje | |
---|---|
Originální název | Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study |
Autoři | GONZALEZ-RIVAS, J. P. (garant), J. I. MECHANICK, J. P. HERNANDEZ, M. M. INFANTE-GARCIA, Iuliia PAVLOVSKA (804 Ukrajina, domácí), J. R. MEDINA-INOJOSA, Sarka KUNZOVA (203 Česká republika), R. NIETO-MARTINEZ, Jan BROZ (203 Česká republika), L. BUSETTO, G. A. M. NETO, F. LOPEZ-JIMENEZ, Jana URBANOVA (203 Česká republika) a G. B. STOKIN. |
Vydání | OBESITY SCIENCE & PRACTICE, HOBOKEN, WILEY, 2021, 2055-2238. |
Další údaje | |
---|---|
Originální jazyk | angličtina |
Typ výsledku | Článek v odborném periodiku |
Obor | 30202 Endocrinology and metabolism |
Stát vydavatele | Spojené státy |
Utajení | není předmětem státního či obchodního tajemství |
WWW | URL |
Kód RIV | RIV/00216224:14110/21:00121638 |
Organizační jednotka | Lékařská fakulta |
Doi | http://dx.doi.org/10.1002/osp4.496 |
UT WoS | 000647238400001 |
Klíčová slova anglicky | adiposity; cardiovascular disease; epidemiology; obesity; overweight |
Štítky | 14110525, rivok |
Příznaky | Mezinárodní význam, Recenzováno |
Změnil | Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 7. 12. 2021 13:01. |
Anotace |
---|
Aims/Hypothesis The need for understanding obesity as a chronic disease, its stigmatization, and the lack of actionability related to it demands a new approach. The adiposity-based chronic disease (ABCD) model is based on adiposity amount, distribution, and function, with a three stage complication-centric rather than a body mass index (BMI)-centric approach. The prevalence rates and associated risk factors are presented. Methods In total, 2159 participants were randomly selected from Czechia. ABCD was established as BMI >= 25 kg/m(2) or high body fat percent, or abdominal obesity and then categorized by their adiposity-based complications: Stage 0: none; Stage 1: mild/moderate; Stage 2: severe. Results ABCD prevalence was 62.8%. Stage 0 was 2.3%; Stage 1 was 31.4%; Stage 2 was 29.1%. Comparing with other classifiers, participants in Stage 2 were more likely to have diabetes, hypertension, and metabolic syndrome than those with overweight, obesity, abdominal obesity, and increased fat mass. ABCD showed the highest sensitivity and specificity to detect participants with peripheral artery disease, increased intima media, and vascular disease. Conclusion/Interpretation The ABCD model provides a more sensitive approach that facilitates the early detection and stratification of participants at risk compared to traditional classifiers. |
VytisknoutZobrazeno: 8. 9. 2024 21:29